MSTN Antikörper

Produktnummer ABIN931337

Der Maus Monoklonal anti-MSTN Antikörper wird verwendet zum Nachweis von MSTN in Proben von Human. Er wurde validiert für WB und ELISA.

Kurzübersicht für MSTN Antikörper (ABIN931337)

Target: MSTN (Myostatin (MSTN))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser MSTN Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Klon: 6H12

Produktdetails anti-MSTN Antikörper

Immunogen: Myostatin antibody was raised in Mouse using a purified recombinant fragment of Myostatin expressed in E. coli as the immunogen.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: 1:10,000, WB: 1:500-1:2000
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Supplied as a liquid in ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C for short term storage. Store at -20 °C for long term storage.

Details zu MSTN

Target: MSTN (Myostatin (MSTN))

Andere Bezeichnung: Myostatin

Hintergrund: Myostatin is a TGF beta family member that acts as an inhibitor of skeletal muscle growth. This muscle-specific cytokine interacts with Activin type I and type II receptors, and suppresses myoblast proliferation by arresting cell-cycle in the G1 phase. Suppression of myostatin activity facilitates muscle formation and may be useful in reducing and/or preventing adiposity and type-2 diabetes. Myostatin activity can be blocked by the Activin-binding protein Follistatin, and by the propeptide of Myostatin. Synonyms: Monoclonal Myostatin antibody, Anti-Myostatin antibody, GDF-8 antibody, GDF 8 antibody, GDF8 antibody.